$SWIM

Latham Group, Inc. (SWIM): Entry into a Material Definitive Agreement

Latham Group, Inc. (SWIM) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On August 20, 2026 (the “Closing Date”), certain subsidiaries of Latham Group, Inc. (the “Company”) entered into the Credit Agreement (the “Credit Agreement”) and the Loan Guaranty, each by and among Latham Pool Products, Inc.

Original reporting
Published Aug 21, 2026, 12:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 1:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$SWIM
Neutral
medium confidence
Mentioned
$SWIM
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SWIMNeutralMed
01

Why it matters

The financing provides immediate capital but introduces new debt obligations, influencing valuation metrics.

02

Market read

Primary disclosure of a material financing deal; relevant for investors monitoring debt exposure and liquidity.

03

What to watch

Potential covenants or restrictive clauses in the agreement that could limit future actions.

Relevance 6/10Novelty 8/10Timing: filing today

Background

SEC Form 8‑K filing discloses Latham Group's entry into a credit agreement with Jefferies Finance and other banks.

Company-level read

Ticker impact

$SWIMNeutralMedium confidence
Context

Latham Group filed an 8‑K reporting entry into a material credit agreement and creation of a direct financial obligation.

Expected impact

Modest short‑term downside risk as investors assess debt terms.

Evidence & confidence

The agreement is a primary disclosure of a material financing event; impact depends on interest rates and covenant terms.

Market effects

May affect other small‑cap financing peers as market gauges credit conditions.

Limited to U.S. small‑cap investors; no broad regional effect.

Low global relevance; primarily a company‑specific financing event.

Counterpoint

If terms are favorable, the infusion could boost growth prospects, offsetting debt concerns.

Key entities

  • Latham Group, Inc.

    Issuer of the credit agreement.

  • Jefferies Finance LLC

    Administrative agent and issuing bank for the credit facility.

Related articles

Med

Latham Group Refinances Capital Structure with New Credit Facilities

Latham Group (SWIM) refinanced its capital structure with new credit facilities totaling $375 million. The facilities include a $75 million revolving credit line and a $300 million term loan, both secured by company assets. Proceeds were used to repay existing debt. The facilities mature in 2031 and 2033, respectively, and include leverage-based interest margins and covenants.

$FULCMedAI 8/10

Latham Advises Frazier Life Sciences on Private Placement Financing in Connection With Fulcrum Therapeutics and Slate Medicines Merger

Fulcrum Therapeutics (Nasdaq: FULC) and Slate Medicines announced a definitive all-stock merger. The combined company will operate as Slate Medicines, Inc. and is expected to trade on Nasdaq as SLTE. Slate secured commitments for an oversubscribed concurrent private placement of $245 million led by Frazier Life Sciences, with other healthcare investors participating.

$SWIMMedAI 8/10

Latham Group (SWIM) Q2 2026 Earnings Call Transcript

Latham Group, Inc. (SWIM) reported Q2 2026 net sales of $197.5 million, up 14.4% year over year, driven by 10.3% organic growth and the Freedom Pools acquisition. Adjusted EBITDA rose to $44.6 million. Net income fell to $12.8 million due to a $5.0 million FX impact. Full-year guidance: net sales $600 million to $620 million, adjusted EBITDA $110 million to $120 million.

$LOGCMedAI 8/10

Latham Represents Blackstone Credit & Insurance in Financing for ContextLogic’s Acquisition of gChem for US$850 Million

ContextLogic Holdings (OTCQB: LOGC) said it will acquire gChem, the holding company of Gaylord Chemical and subsidiaries, from funds managed by EagleTree Capital and co-investors. The deal values gChem at an enterprise value of US$850 million. Financing will come from Blackstone Credit & Insurance, including a US$250 million term loan and US$25 million revolver, per the company.